#IPVSPaperOfTheWeek
A study by Giesbrecht et al. on wastewater testing reveals 24 circulating HPV types in Canada, including high-risk and vaccine-preventable types like HPV-16 and -18. A promising tool for public health surveillance. @umanitoba.bsky.social

➡️ bit.ly/44CnCRC

#IPVSPaperOfTheWeek
July 11, 2025 at 7:17 AM
#PersistentInfection of HPV requires genome maintenance and partitioning during cell division, but #LiveCellMonitoring tools were lacking. This study applies #ANCHOR technology to visualise HPV18 genome tethering, providing a tool for therapy development. ➡️bit.ly/3ITp8Yu

#IPVSPaperoftheWeek
August 1, 2025 at 6:55 AM
People with HIV are at higher risk for head and neck cancer.

Recent study found that HIV was associated with 43 % higher hazard of death for oropharyngeal cancer. Read the paper➡️bit.ly/46qm9QV Paper highlights have been summarized 👇
#IPVSPaperoftheWeek #HPVResearch
July 25, 2025 at 8:49 AM
New paper published in the JNCI: Journal of the National Cancer Institute on racial and ethnic heterogeneity in #HPV-related cancers by anatomical site 👉https://bit.ly/43hE5Kb

#IPVSPaperOfTheWeek #Epidemiology #HPVCancer
May 16, 2025 at 7:40 AM
Can HPV in semen affect fertility outcomes? This prospective cohort study examined HPV prevalence in infertile men and its potential impact on ART success. While no major effects were found, subtle trends suggest HPV status may still matter.

Read the paper👉bit.ly/3Tkt1aC

#IPVSPaperOfTheWeek
June 13, 2025 at 5:34 AM
Celebrating 164 IPVS Papers of the Week since June 2022! 🎉

Thank you to all authors and IPVS Social Media Committee members for your efforts and hard work.

Here’s to more milestones ahead!

💡Members can explore all papers on the IPVS Education Center: bit.ly/4hahmqk

#IPVSPaperOfTheWeek
October 10, 2025 at 7:17 AM
#HPV vaccination is expanding globally, yet coverage remains far below elimination targets. This systematic review maps national programs and highlights persistent inequities, urging stronger delivery strategies to close the gap.

📄 Read the paper: bit.ly/4nwJ9CH

#IPVSPaperoftheWeek
October 31, 2025 at 7:39 AM
Large, long-term Swedish cohort study shows 1–2 doses of quadrivalent #HPVvaccine before age 15 protect against high-grade cervical lesions comparable to 3 doses.

📄 Full paper: bit.ly/4oR90au

Paper highlights ⬇️

#IPVSPaperoftheWeek
August 15, 2025 at 7:21 AM
HPV test results aren’t just "new infection vs clearance": many are reactivations or low-level persistence. A new #IPVS review urges framing as “HPV detected” vs “not detected” to better guide counseling, screening & vaccination.

Read more 👉https://bit.ly/4cUR09k
#IPVSPaperOfTheWeek
May 2, 2025 at 6:57 AM
Recent study among 2335 adolescent girls and young adult women found population-level effectiveness and herd protection were robust 17 years after #HPV #vaccine introduction.

📄 Read the paper: bit.ly/47b5Nul
Paper highlights ⬇️

@einsteinmededu.bsky.social @jamapediatrics.com
#IPVSPaperoftheWeek
October 17, 2025 at 7:18 AM
A global systematic review reveals most (148/194) countries have introduced HPV vaccination, but coverage among girls aged 9–14 remains far below target. Coverage is highest in upper-middle-income countries, indicating geographic disparities.

📄 bit.ly/4mWLVBF
Paper highlights ⬇️

#IPVSPaperoftheWeek
September 12, 2025 at 7:30 AM
Recent study in India found the presence of HPV58 and HPV59 in #oropharyngeal #cancer cases. The HPV burden at this site may expand beyond just HPV16/18. Tobacco and alcohol still remain important risk factors for this cancer.

📄 Read the paper: bit.ly/3Jl5aGm
Paper highlights ⬇️
#IPVSPaperoftheWeek
August 22, 2025 at 6:44 AM
A woman with an immune defect developed #betaHPV–integrated skin cancer. Stem-cell transplant restored T-cell function and cleared all HPV diseases — revealing the direct #carcinogenicity of β-HPV under immune deficiency. ➡️ bit.ly/3HwYRis

Paper highlights have been summarized ⬇️

#IPVSPaperoftheWeek
August 29, 2025 at 5:15 AM
New study published in the JNCI: Journal of the National Cancer Institute on the risk of #HPV-related squamous cell carcinomas in 7936 survivors of autologous or allogeneic blood or marrow transplantation #openaccess: bit.ly/3RIvcUE

#HPV #IPVSPaperOfTheWeek
April 11, 2025 at 7:26 AM
A US study using a 20-year Markov model found that when women newly diagnosed with cervical cancer are screened for anal HPV, evaluated for epithelial dysplasia, and treated for anal HSIL, they’re less likely to develop or die from anal cancer. ➡️ bit.ly/43OwDr7

#IPVSPaperoftheWeek
November 7, 2025 at 7:41 AM
New hope for penile cancer: Trop-2 is highly expressed in HPV-positive tumors, supporting sacituzumab govitecan as a promising targeted therapy. Nectin-4 expression is limited—biopsy of metastases is key before treatment.

Read the paper 👉 bit.ly/4kebgFC

#IPVSPaperOfTheWeek #cancerresearch
May 9, 2025 at 6:50 AM
New global analysis shows major inequities in #CervicalCancer screening and follow-up. Integrating #SelfCollection and #HPV point-of-care testing is a promising step toward equitable #Screening and #CancerControl. ➡️ bit.ly/46816Rx

Paper highlights have been summarized ⬇️

#IPVSPaperoftheWeek
September 5, 2025 at 6:42 AM
Nuclear K6A boosts #HPV16 oncogene expression via TEAD1, offering insight into #viral-gene-regulation, cervical cancer development, and cell-type-specific oncogenic susceptibility.

Read the paper➡️bit.ly/46qhcHK

#IPVSPaperoftheWeek
July 4, 2025 at 6:30 AM
#BetaHPV49, linked to skin cancer, uses a splice site in E6 previously seen only in #highrisk alpha-HPV. This site regulates E6 levels and is essential for keratinocyte immortalisation, revealing similarities in #viralpathogenesis.

Read the paper 👉https://bit.ly/4dTHST5

#IPVSPaperOfTheWeek
June 6, 2025 at 6:56 AM
New study in Annals of Internal Medicine: anal cancer screening is cost-effective for MSM living with HIV aged 35+➡️ bit.ly/40VTakk

Paper highlights have been summarized 👇

#IPVSPaperoftheWeek #HPV #HIV #CancerScreening
July 18, 2025 at 6:43 AM